Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

23.80p
   
  • Change Today:
      1.80p
  • 52 Week High: 45.85
  • 52 Week Low: 17.70
  • Currency: UK Pounds
  • Shares Issued: 741.51m
  • Volume: 2,445,829
  • Market Cap: £176.48m
  • Beta: 0.02

Dividend Data

  30-Sep-2430-Sep-2330-Sep-2230-Sep-2130-Sep-20
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Continuing Operations          
Revenue 90.36 103.96 157.71 125.06 105.57
Operating Profit/(Loss) (35.50) (17.53) (6.23) (5.38) (11.02)
Net Interest (10.33) (19.52) (15.15) (3.80) (11.70)
Profit Before Tax (45.92) (24.70) (21.38) (9.18) (22.57)
Profit After Tax (45.92) (24.70) (28.65) (11.58) (22.77)
Discontinued Operations          
Profit After Tax n/a n/a (1.80) n/a (9.17)
PROFIT FOR THE PERIOD (45.92) (24.70) (30.45) (11.58) (31.95)
Attributable to:          
Equity Holders of Parent Company (45.92) (24.70) (30.45) (12.89) (32.92)
Minority Interests n/a n/a n/a 1.32 0.97
           
Continuing EPS          
Earnings per Share - Basic (5.99p) (3.21p) (4.34p) (1.93p) (3.80p)
Earnings per Share - Diluted (5.99p) (3.21p) (4.34p) (1.93p) (3.80p)
Earnings per Share - Adjusted (5.99p) (3.21p) (4.34p) (1.93p) (3.80p)
Continuing and Discontinued EPS          
Earnings per Share - Basic (5.34p) (3.16p) (4.60p) (1.93p) (5.26p)
Earnings per Share - Diluted (5.34p) (3.16p) (4.60p) (1.93p) (5.26p)
Earnings per Share - Adjusted (5.34p) (3.16p) (4.60p) (1.93p) (5.26p)
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 14.16 93.21 108.93 104.31 75.95
Intangible Assets 115.53 206.08 245.26 229.04 247.00
Investment Properties n/a n/a n/a n/a n/a
Investments 2.32 3.57 0.01 0.01 0.02
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets n/a 18.41 23.99 24.60 20.31
  132.00 321.27 378.20 357.96 343.29
Current Assets          
Inventories 23.67 25.27 29.81 20.95 18.93
Trade & Other Receivables 42.54 59.79 56.38 46.50 39.37
Cash at Bank & in Hand 23.09 36.53 36.40 39.46 71.61
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 0.35 27.59 25.78 17.12 15.85
  89.65 149.17 148.37 124.03 145.75
           
Other Assets 163.25 0.85 n/a n/a n/a
Total Assets 384.90 471.30 526.57 481.99 489.04
           
Liabilities          
Current Liabilities          
Borrowings 2.84 81.95 17.09 10.65 5.34
Other Current Liabilities 11.53 31.65 56.17 52.87 50.04
  14.37 113.60 73.26 63.52 55.37
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 69.23 20.05 93.04 109.74 103.82
Provisions 0.23 1.28 27.99 28.22 32.65
Other Non-Current Liabilities 76.80 53.75 9.00 0.91 1.75
  146.27 75.08 130.03 138.87 138.22
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 160.63 188.68 203.29 202.39 193.60
           
Net Assets 224.27 282.62 323.29 279.60 295.44
           
Capital & Reserves          
Share Capital 38.23 38.17 0.70 0.67 0.67
Share Premium Account n/a n/a n/a 400.68 n/a
Other Reserves 33.95 54.75 497.83 (160.10) 430.63
Retained Earnings 146.08 183.49 (185.14) 30.47 (142.17)
Shareholders Funds 218.26 276.40 313.40 271.71 289.13
           
Minority Interests/Other Equity 6.01 6.21 9.89 7.88 6.31
Total Equity 224.27 282.62 323.29 279.60 295.44
Cash Flow 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Net Cash Flow From Operating Activities 2.00 20.00 10.81 5.79 (4.06)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (2.83) (5.27) (11.22) (23.09) 30.38
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (10.97) (12.33) (6.92) (14.67) 30.13
Net Increase/Decrease In Cash (11.80) 2.41 (7.33) (31.97) 56.45
Ratios - based on IFRS 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 12.19p 14.02p 21.27p 0.17p 14.24p
Pre-Tax Profit per Share (6.19p) (3.33p) (2.88p) (0.012p) (3.04p)
Operating Margin (39.28%) (16.87%) (3.95%) (4.30%) (10.44%)
Return on Capital Employed n/a n/a n/a n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 0.27p 2.70p 1.46p 0.78p (0.55p)
Cash Incr/Decr per Share (1.59p) 0.32p (0.99p) (0.044p) 7.61p
Net Asset Value per Share (exc. Intangibles) 14.66p 10.32p 10.52p 6.82p 6.53p
Net Gearing 22.44% 23.69% 23.53% 29.79% 12.99%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page